Correlation Between Chugai Pharmaceutical and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Chugai Pharmaceutical and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chugai Pharmaceutical and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chugai Pharmaceutical Co and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Chugai Pharmaceutical and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chugai Pharmaceutical with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chugai Pharmaceutical and Takeda Pharmaceutical.

Diversification Opportunities for Chugai Pharmaceutical and Takeda Pharmaceutical

0.56

Correlation Coefficient

Chugai Pharmaceutical  Takeda Pharmaceutical

Very weak diversification

The 3 months correlation between Chugai and Takeda is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Chugai Pharmaceutical Co and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Chugai Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chugai Pharmaceutical Co are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Chugai Pharmaceutical i.e., Chugai Pharmaceutical and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Chugai Pharmaceutical and Takeda Pharmaceutical

Assuming the 90 days horizon Chugai Pharmaceutical Co is expected to under-perform the Takeda Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Chugai Pharmaceutical Co is 1.15 times less risky than Takeda Pharmaceutical. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Takeda Pharmaceutical Co is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,734  in Takeda Pharmaceutical Co on October 6, 2024 and sell it today you would lose (59.00) from holding Takeda Pharmaceutical Co or give up 2.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Chugai Pharmaceutical Co  vs.  Takeda Pharmaceutical Co

Chugai Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Chugai Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Chugai Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Chugai Pharmaceutical and Takeda Pharmaceutical

The main advantage of trading using opposite Chugai Pharmaceutical and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chugai Pharmaceutical position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Chugai Pharmaceutical Co and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.